Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC100506406 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SSX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CIITA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
JRK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TPTEP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LINC01255 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SH2D1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100132356 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANXA2P3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MEGF9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100507855 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC6A13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100507065 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TLE6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADCYAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AGPS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on